Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia.
University of Nicosia, School of Medicine, Nicosia, Cyprus.
Am J Cardiol. 2023 Jan 15;187:48-53. doi: 10.1016/j.amjcard.2022.10.037. Epub 2022 Nov 29.
Williams-Beuren syndrome (WBS) is a genetic condition frequently requiring interventions for associated congenital heart disease (CHD). Long-term survival data after cardiac interventions for children with WBS are sparse. This is a retrospective cohort study aiming to describe the 30-year survival outcomes of children with WBS after interventions for CHD using the Pediatric Cardiac Care Consortium (PCCC), a large North American-based registry of interventions for pediatric heart diseases, between 1982 and 2009. Outcomes were obtained from the PCCC and by linkage with the National Death Index through 2020. Survival of patients with WBS and their major subgroups was assessed by Kaplan-Meier survival curves and Cox regression. A total of 200 patients met the inclusion criteria of having their first intervention for CHD at a US PCCC center and age <21 years at time of intervention. The most common lesions were left heart obstructive lesions (LHOL), either in isolation (37%) or in combination with right heart obstructive lesions (RHOL) (49.0%), whereas isolated RHOL accounted for 11% of the total. The first procedure was surgery for 85.5% of the group, and the remainder underwent a transcatheter procedure. There were 5 in-hospital deaths (2.5%), and among survivors to hospital discharge, 164 had sufficient identifiers for National Death Index linkage. Over a median period of postdischarge follow-up of 23.7 years (interquartile range 18.7 to 27.3), 16 deaths occurred, with an overall 30-year survival rate of 90%. Survival rates ranged from 96.1% for isolated LHOL or RHOL to 83.4% for patients with combined disease (adjusted hazard ratio 4.7, 95% confidence intervals 1.35 to 16.59).
威廉姆斯-比伦综合征(WBS)是一种常需干预治疗相关先天性心脏病(CHD)的遗传疾病。WBS 患儿心脏介入治疗后的长期生存数据较为匮乏。本研究为回顾性队列研究,旨在利用北美大型儿科心脏疾病介入治疗注册研究组织-儿科心脏护理联合会(PCCC),描述 1982 年至 2009 年期间,WBS 患儿因 CHD 行介入治疗后 30 年的生存结局。结局数据通过 PCCC 及与国家死亡指数的链接获取,随访至 2020 年。采用 Kaplan-Meier 生存曲线和 Cox 回归评估 WBS 患儿及其主要亚组的生存情况。共有 200 名患儿符合纳入标准,即在 PCCC 中心接受首次 CHD 介入治疗且介入治疗时年龄<21 岁。最常见的病变为左心梗阻性病变(LHOL),单独存在(37%)或与右心梗阻性病变(RHOL)同时存在(49.0%),而孤立性 RHOL 占总数的 11%。85.5%的患儿接受了手术治疗,其余患儿则接受了经导管治疗。院内死亡 5 例(2.5%),存活至出院的患儿中,有 164 例有足够的身份识别信息与国家死亡索引进行链接。在出院后中位随访期 23.7 年(四分位距 18.7 至 27.3)内,共发生 16 例死亡,总体 30 年生存率为 90%。生存率范围为孤立性 LHOL 或 RHOL 患儿的 96.1%至合并疾病患儿的 83.4%(校正风险比 4.7,95%置信区间 1.35 至 16.59)。